A detailed history of Cresset Asset Management, LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 29,206 shares of LNTH stock, worth $2.64 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
29,206
Previous 28,443 2.68%
Holding current value
$2.64 Million
Previous $2.28 Million 40.39%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$77.7 - $123.62 $59,285 - $94,322
763 Added 2.68%
29,206 $3.21 Million
Q2 2024

Aug 14, 2024

BUY
$58.87 - $83.05 $182,261 - $257,122
3,096 Added 12.21%
28,443 $2.28 Million
Q1 2024

May 15, 2024

BUY
$51.07 - $68.26 $1.29 Million - $1.73 Million
25,347 New
25,347 $1.58 Million
Q2 2019

Aug 12, 2019

SELL
$23.33 - $28.3 $536 - $650
-23 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$14.93 - $25.1 $343 - $577
23 New
23 $1,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.22B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.